A 3D in vitro model reveals differences in the astrocyte response elicited by potential stem cell therapies for CNS injury.
暂无分享,去创建一个
Emma East | James B Phillips | Melanie Georgiou | P. Kingham | J. Phillips | Melanie Georgiou | A. J. Loughlin | J. Golding | Jon P Golding | Paul J Kingham | Noémie Johns | A Jane Loughlin | N. Johns | E. East
[1] Rohini Billakanti,et al. Reactive Astrogliosis after Spinal Cord Injury—Beneficial and Detrimental Effects , 2012, Molecular Neurobiology.
[2] K. Bhakoo,et al. Homing of stem cells to sites of inflammatory brain injury after intracerebral and intravenous administration: a longitudinal imaging study , 2010, Stem Cell Research & Therapy.
[3] R. Rosenwasser,et al. Changes in Host Blood Factors and Brain Glia Accompanying the Functional Recovery after Systemic Administration of Bone Marrow Stem Cells in Ischemic Stroke Rats , 2010, Cell transplantation.
[4] Yuzo Takayama,et al. Network-wide integration of stem cell-derived neurons and mouse cortical neurons using microfabricated co-culture devices , 2012, Biosyst..
[5] Dana Mareková,et al. Transplantation of Predifferentiated Adipose-Derived Stromal Cells for the Treatment of Spinal Cord Injury , 2011, Cellular and Molecular Neurobiology.
[6] Evon M. O. Abu-Taieh,et al. Comparative Study , 2020, Definitions.
[7] R. Franklin,et al. Olfactory ensheathing cells induce less host astrocyte response and chondroitin sulphate proteoglycan expression than schwann cells following transplantation into adult cns white matter , 2003, Experimental Neurology.
[8] G. Ning,et al. Combination of activated Schwann cells with bone mesenchymal stem cells: the best cell strategy for repair after spinal cord injury in rats. , 2011, Regenerative medicine.
[9] M. Grãos,et al. The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations , 2012, Stem Cell Research & Therapy.
[10] Mikael Wiberg,et al. Adipose-derived stem cells differentiate into a Schwann cell phenotype and promote neurite outgrowth in vitro , 2007, Experimental Neurology.
[11] L. Olson,et al. Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury. , 2009, Restorative neurology and neuroscience.
[12] Jerry Silver,et al. Regeneration beyond the glial scar , 2004, Nature Reviews Neuroscience.
[13] M. Fehlings,et al. A systematic review of cellular transplantation therapies for spinal cord injury. , 2011, Journal of neurotrauma.
[14] Thomas B. DeMarse,et al. Adult neural progenitor cells reactivate superbursting in mature neural networks , 2012, Experimental Neurology.
[15] Y. Tabata,et al. Mesenchymal stem cells as therapeutic agents and potential targeted gene delivery vehicle for brain diseases. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[16] Emma East,et al. A versatile 3D culture model facilitates monitoring of astrocytes undergoing reactive gliosis , 2009, Journal of tissue engineering and regenerative medicine.
[17] Yi Li,et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells , 2005, Glia.
[18] J. Golding,et al. Border Controls at the Mammalian Spinal Cord: Late-Surviving Neural Crest Boundary Cap Cells at Dorsal Root Entry Sites May Regulate Sensory Afferent Ingrowth and Entry Zone Morphogenesis , 1997, Molecular and Cellular Neuroscience.
[19] J. Riddell,et al. A comparative study of glial and non‐neural cell properties for transplant‐mediated repair of the injured spinal cord , 2013, Glia.
[20] M. Sieber-Blum. Epidermal neural crest stem cells and their use in mouse models of spinal cord injury , 2010, Brain Research Bulletin.
[21] Emma East,et al. Engineering an integrated cellular interface in three-dimensional hydrogel cultures permits monitoring of reciprocal astrocyte and neuronal responses. , 2012, Tissue engineering. Part C, Methods.
[22] J. Fang,et al. Transplantation of Schwann Cells Differentiated from Adipose-Derived Stem Cells Modifies Reactive Gliosis after Contusion Brain Injury in Rats , 2011, The Journal of international medical research.
[23] O. Lindvall. Why is it taking so long to develop clinically competitive stem cell therapies for CNS disorders? , 2012, Cell stem cell.
[24] G. Biella,et al. Mesenchymal stem cells enhance GABAergic transmission in co-cultured hippocampal neurons , 2012, Molecular and Cellular Neuroscience.
[25] Martin E. Schwab,et al. Characterization of epidermal neural crest stem cell (EPI-NCSC) grafts in the lesioned spinal cord , 2006, Molecular and Cellular Neuroscience.
[26] M. Sofroniew,et al. Reactive astrocytes as therapeutic targets for CNS disorders , 2010, Neurotherapeutics.
[27] E. Gilerovich,et al. Mesenchymal stem cells transplantation could be beneficial for treatment of experimental ischemic stroke in rats , 2008 .
[28] Y. Son,et al. Schwann cells differentiated from spheroid-forming cells of rat subcutaneous fat tissue myelinate axons in the spinal cord injury , 2010, Experimental Neurology.
[29] P. Trainor,et al. Neural crest stem cells: discovery, properties and potential for therapy , 2012, Cell Research.
[30] M. Chopp,et al. Bone marrow stromal cells reduce ischemia-induced astrocytic activation in vitro , 2008, Neuroscience.
[31] A. Grigorian,et al. Effect of transplantation of mesenchymal stem cells on neuronal survival and formation of a glial scar in the brain of rats with severe traumatic brain injury , 2011, Bulletin of Experimental Biology and Medicine.
[32] E. Bradbury,et al. Manipulating the glial scar: Chondroitinase ABC as a therapy for spinal cord injury , 2011, Brain Research Bulletin.
[33] L. Probert,et al. Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function , 2012, Experimental Neurology.